BioSpace News Archive

Therma Bright to Submit Application to Health Canada for Approval of its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

Therma Bright Inc. (TSXV: THRM) (“Therma” or the “Company”), a progressive medical device technology company, is pleased to announce that it will submit an application to Health Canada for review of the Company’s AcuVid™ COVID-19 Rapid Antigen Saliva Test for detecting SARS CoV-2 virus in saliva.

May 10, 2022
·
4 min read
BioCapital

National Spine and Pain Centers to Open a Surgery Center in Texas

National Spine and Pain Centers, the nation’s leading network of minimally invasive spine and pain physicians, announced the addition of a new ambulatory surgery center in Dallas.

May 10, 2022
·
2 min read
Biotech Bay

Minerva Surgical to Present at Upcoming Investor Conferences - May 10, 2022

Minerva Surgical, Inc., a woman’s health company focused on the treatment of Abnormal Uterine Bleeding, announced that its management will present at the following investor conferences:

May 10, 2022
·
1 min read
Biotech Bay

LARGEST CLINICAL STUDY VALIDATING A BLOOD-BASED COLORECTAL SCREENING TEST COMPLETES ENROLLMENT

Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the company’s large, prospective study to validate its blood test for colorectal cancer (CRC) screening among average-risk adults.

May 10, 2022
·
4 min read
BioMidwest

Inhibikase Therapeutics to Participate at the H.C. Wainwright Global Investment Conference

Inhibikase Therapeutics, Inc. announced that Dr. Milton Werner, Ph.D., the Company’s President & Chief Executive Officer will present at the upcoming H.C. Wainwright Global Investment Conference being held in Miami Beach, FL on May 25, 2022 at 2:30 pm ET.

May 10, 2022
·
2 min read
Business

Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Frédéric Matonti, a Leading Ophthalmology Specialist

Vect-Horus announced the appointment of Pr. Frédéric Matonti to its scientific advisory board.

May 10, 2022
·
2 min read
Pharm Country

Instem Awarded EMA Research Grant

Instem announced that it has been awarded a European Medicines Agency grant as part of an EMA-funded research project to better understand the mutagenicity of N-nitrosamines.

May 10, 2022
·
3 min read
Pharm Country

Imvax to Present at Two Investor Conferences in May 2022

Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, announced that Chief Executive Officer John P. Furey will be presenting at the following upcoming investor conferences.

May 10, 2022
·
1 min read
Pharm Country

Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry: for people affected by pelvic radiation during cancer treatment

Lipella Pharmaceuticals, Inc. is announcing the Radiation Cystitis Patient Registry, an on-line patient registry program for people who are affected by pelvic radiation exposure, including survivors of pelvic cancers, such as prostate, uterine, cervical and colon cancer.

May 10, 2022
·
2 min read
Genetown

Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022

Zealand Pharma A/S announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders:

May 10, 2022
·
2 min read